Article

HHS Outlines Health IT Innovation Projects

HHS is looking for five to 10 technology innovators to work in the first round of a program seeking to bring some private-sector entrepreneurial spirit to bear on national healthcare challenges.

Read the full story: http://tinyurl.com/7taay5w

Source: ModernHealthcare.com

Private-sector participants—so-called external innovation fellows—in HHS' Innovation Fellows Program will be paired with HHS employees who have already applied for the program to address four projects, three of which have health information technology components.

Related Videos
Katrina Ortblad, ScD, MPH, Fred Hutch Cancer Center
Michelle Hessen, OD
Douglas Flora, MD, FACCC
Molly Dean, MSW, Siftwell
Dr Xin Hu
Bridgette J. Picou, LVN, ACLPN, The Well Project
Priscilla Tsondai, MD, MPH, IAS/CIPHER
Mia Moore, PhD, Fred Hutch Cancer Center
rachel rohaidy
Related Content
Drug costs in US | Image Credit: © Kenishirotie - stock.adobe.com
March 13th 2025

Contributor: The Role of Dynamic Pricing in Health Technology Assessment for MDD

Dominique Seo, MPH Larragem Raines, MS Rick Chapman, PhD
Incorporating dynamic pricing into cost-effectiveness analysis could offer significant benefits for equity in health care.
Managed Care Cast Logo
February 25th 2025

Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care

Pearl Steinzor Arthur L. Jenkins III, MD, FACS
On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.
Lipid metabolite assays could be a potential noninvasive diagnostic alternative for patients with MASH who otherwise may need a liver biopsy | image credit: Vlad - stock.adobe.com
March 13th 2025

Lipid Metabolites Emerge as Noninvasive Diagnostic Tool in MASH

Kyle Munz
The invasive nature of lipid biopsies has lead researchers to dedicate more efforts to unveiling noninvasive diagnostic methods for metabolic dysfunction–associated steatohepatitis (MASH).
managed care cast logo
February 18th 2025

Varied Access: The Pharmacogenetic Testing Coverage Divide

Brooke McCormick Jai N. Patel, PharmD
On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
ART | Image credit: gamjai - stock.adobe.com
March 13th 2025

Late-Breaking Antiviral Session Features Phase 3 Results on Efficacy of Doravirine/Islatravir

Julia Bonavitacola
The combination of doravirine plus islatravir was noninferior to bictegravir/emtricitabine/tenofovir alafenamide and oral antiretroviral therapy in patients who switched to doravirine plus islatravir.
Pittsburgh, Pennsylvania | Image Credit: © SeanPavonePhoto - stock.adobe.com
March 13th 2025

Reducing Care Fragmentation to Boost CKM Disease Outcomes

Maggie L. Shaw
Discussions at a recent Institute for Value-Based Medicine® event highlighted the interconnected nature of cardio-kidney-metabolic disease and emphasized the need for integrated, patient-centered care.

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo